|
Market Closed -
Canadian Securities Exchange
15:51:37 2026-08-27 EDT
|
5-day change | 1st Jan Change | ||
| 0.3600 CAD | +5.88% |
|
+4.35% | -43.75% |
| Market Cap | 48.98M 35.33M 30.33M 28.39M 26M 3.37B 49.12M 336M 131M 1.7B 133M 130M 5.63B | P/E 2024 |
-7.97x | P/E 2025 | -10.8x |
|---|---|---|---|---|---|
| Enterprise Value | 54.87M 39.58M 33.98M 31.81M 29.13M 3.78B 55.03M 377M 147M 1.91B 149M 145M 6.31B | EV / Sales 2024 |
1,754x | EV / Sales 2025 | - |
| Free-Float |
94.6% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +5.88% | ||
| 1 week | +4.35% | ||
| Current month | +20.00% | ||
| 1 month | +18.03% | ||
| 3 months | -19.10% | ||
| 6 months | -40.00% | ||
| Current year | -43.75% |
| 1 week | 0.3 | 0.38 | |
| 1 month | 0.3 | 0.38 | |
| Current year | 0.28 | 0.69 | |
| 1 year | 0.28 | 1.04 | |
| 3 years | 0 | 1.1 | |
| 5 years | 0 | 1.74 | |
| 10 years | 0 | 3.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wolfgang Probst
CEO | Chief Executive Officer | 45 | 2017-12-11 |
Hugh Rogers
CEO | Chief Executive Officer | 46 | 2017-12-11 |
Wolfgang Wagner
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Hugh Rogers
BRD | Director/Board Member | 46 | 2017-12-11 |
Raimar Löbenberg
BRD | Director/Board Member | 60 | 2018-12-09 |
Wolfgang Probst
BRD | Director/Board Member | 45 | 2017-12-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/31/26 | Option | Director | 100,000 | 0.0769% | ||
| 7/31/26 | Option | Chief Financial Officer | 100,000 | 0.0769% | ||
| 7/31/26 | Option | Founder | 650,000 | 0.5000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +5.88% | +4.35% | -64.36% | -5.26% | 33.31M | ||
| -1.12% | -5.49% | +60.19% | +112.43% | 1,060B | ||
| -1.57% | -0.60% | +50.33% | +59.86% | 651B | ||
| -1.81% | -1.41% | +24.07% | +75.98% | 465B | ||
| -1.17% | -2.10% | +38.61% | +40.43% | 365B | ||
| -2.00% | -1.35% | +22.22% | +38.92% | 300B | ||
| -0.98% | +0.53% | +2.04% | +12.13% | 258B | ||
| -0.76% | +0.75% | +51.75% | +70.45% | 238B | ||
| -3.18% | -0.30% | -17.23% | -53.79% | 210B | ||
| +0.52% | +3.78% | +30.67% | +93.68% | 184B | ||
| Average | -0.62% | -0.21% | +19.83% | +44.48% | 373.04B | |
| Weighted average by Cap. | -1.36% | -1.46% | +38.43% | +65.86% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 26.98K 19.47K 16.71K 15.64K 14.32K 1.86M 27.06K 185K 72.42K 937K 73.08K 71.51K 3.1M | - |
| Net income | -5.31M -3.83M -3.29M -3.08M -2.82M -366M -5.33M -36.46M -14.25M -184M -14.39M -14.07M -610M | -7.03M -5.07M -4.35M -4.07M -3.73M -484M -7.05M -48.23M -18.85M -244M -19.03M -18.62M -807M |
| Net Debt | 4.25M 3.06M 2.63M 2.46M 2.25M 293M 4.26M 29.16M 11.4M 147M 11.5M 11.26M 488M | 5.89M 4.25M 3.65M 3.42M 3.13M 406M 5.91M 40.44M 15.81M 205M 15.96M 15.61M 677M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-27 | $0.3600 | +5.88% | 18,500 |
| 26-08-26 | $0.3400 | +3.03% | 53,634 |
| 26-08-25 | $0.3300 | -1.49% | 54,250 |
| 26-08-24 | $0.3350 | -1.47% | 9,250 |
| 26-08-21 | $0.3400 | -1.45% | 100,500 |
- Stock Market
- Stocks
- BNXT Stock
Select your edition
All financial news and data tailored to specific country editions
















